Summary
In E. coli, the master transcription regulator Cra regulates >100 genes in central metabolism by binding upstream DNA operator sequences. Genes encoding glycolytic enzymes are repressed, whereas those for gluconeogenesis and the citric acid cycle are activated. Cra-DNA binding is allosterically diminished by binding to either fructose-1-phosphate (F-1-P, generated upon fructose import) or fructose-1,6-bisphosphate (F-1,6-BP). F-1,6-BP is generated from F-1-P by the enzyme fructose-1-kinase (FruK) or from other sugars and is a key intermediate in glycolysis. Here, we report that Cra directly interacts with FruK to form a tight protein-protein complex. Further, growth assays with a fruK knockout strain show that FruK has a broader role in metabolism than its known role in fructose catabolism. Biochemical experiments show that F- Second, Cra represses the fruBAK operon that encodes the FruK protein (Geerse et al., 1989 , Geerse et al., 1986 , Ramseier et al., 1993 . Thus, in addition to the indirect effects, the LLhFFruK interaction raised the possibility of a direct interaction between wild-type, full-length Cra and FruK.
To test that idea, wild-type Cra was overexpressed in E.coli and the pull-down assay was repeated using the consensus, perfectly palindromic (Saier & Ramseier, 1996) O cra DNA binding site. In MOPS-glycerol media, cells expressing Cra protein did not pull-down FruK Since both Cra and the LLhF chimera bound to FruK, we conclude that the kinase binds to the regulatory domain(s) of Cra. To evaluate the binding affinity between wild-type Cra and
FruK, pull-down assays were repeated with various concentrations of partially purified Cra and FruK (Supplementary Figure 1) . From these experiments, the K d for the interaction was estimated to be <10 -7 M.
Deletion of the fruK gene impairs the switch from rich to glycerol minimal media
Based on our discovery of the Cra-FruK complex, we hypothesized that FruK plays a larger role in the Cra regulon. The only widely-known role of FruK has been in fructose metabolism; when fructose is the only available carbon source, deletion/interruption of the fruK gene abolishes E. coli growth (Ferenci & Kornberg, 1973) . If the hypothesis above is correct, then deletion of the fruK gene should affect bacterial growth on other carbon sources. Indeed, using a fruK mutant strain, Molchanova et al. documented a growth defect on lactate and a corresponding decrease in PEP-synthase required for gluconeogenesis (Molchanova et al., 1992) . Genes for the latter pathway are activated by Cra (Chin et al., 1989 ).
To further demonstrate the global metabolic role of FruK, we grew both wild-type and fruK deletion E. coli strains (see Experimental Procedures for strain genotypes) in LB media and used them to inoculate glucose-and glycerol minimal media. Glucose enters metabolism upstream of F-1,6-BP and proceeds through glycolysis to the TCA cycle. Glycerol enters metabolism downstream of F-1,6-BP, via formation of dihydroxyacetone phosphate (DHAP) and can feed into the TCA cycle and can facilitate gluconeogenesis ( Figure 3 ) (Mazumdar et al., 2010 , Murarka et al., 2008 . Finally, fructose minimal media was used as a control condition.
The transition from LB to minimal media resulted in two-phase growth curves (Figure 4) that are reminiscent of the diauxic curves observed when E. coli switch between carbon sources (Monod, 1947) . In the glucose growth conditions, both the wild-type and Δ fruk strains showed essentially identical growth curves ( Figure 4A ). As expected, the Δ fruk strain showed no growth on fructose after 24 hours, whereas the wild-type strain showed robust growth. However, in glycerol minimal media, the Δ fruk strain showed a significant increase in the diauxic lag time relative to the wild-type strain ( Figure 4B -C). Subsequent to the lag, the rates of the exponential growth phases of the wild-type and deletion strains were very similar to each other ( Figure 4D ). 
Confirmation of FruK enzymatic activity
To confirm the kinetic activity of purified FruK, we first replicated the published assay that coupled the FruK reaction to those of aldolase C, glycerophosphate dehydrogenase, and triose phosphate isomerase (Veiga-da-Cunha et al., 2000) . From this, we determined a K m value of 0.4 mM, in reasonable agreement with the previously published value of 0.13 mM (Veiga-da-Cunha et al., 2000) . However, different lots of commercial muscle aldolase C had varied background activity for F-1-P, which could arise from contamination with other aldolase isozymes (Lebherz & Rutter, 1969 
Using several preparations of FruK, we found that K m for F-1-P is in the range of 0.5-2 mM ( Figure 5 ).
To determine whether the interaction with Cra could regulate the enzymatic activity of FruK, we desired to add purified Cra to purified FruK. However, control reactions showed that Cra was contaminated with small amounts of FruK. The FruK contaminant was confirmed by SDS-PAGE using either over-loaded purified Cra or Cra pull-down samples (i.e. Supplementary   Figure 1 , left gel, lanes 1 and 2). To date, we have been unable to purify Cra from fruk deletion strains of E.coli. (Although Cra is expressed, it does not survive ammonium sulfate precipitation). Thus, we instead compared K m for F-1-P of purified FruK with that for copurifying Cra/FruK; values were statistically identical, even in the presence of operator DNA sequences. We were unable to compare values for V max because the extremely low concentration of FruK could not be accurately quantified in the co-purified Cra/FruK sample.
The FruK activity in the co-purified Cra/FruK sample confirms the identity of the FruK protein, and the ever-present contamination of FruK in our Cra preparations provide further evidence to the strength of the Cra/FruK interaction. In addition, results for the FruK activity in the complex have three possible interpretations: (i) The Cra/FruK interaction has no effect on K m for F-1-P.
(ii) The Cra/FruK complex cannot form in the presence of high concentrations of F-1-P needed to carry out the assay. (iii) The FruK enzyme activity is only altered when the Cra/FruK complex is bound to DNA; however, the ternary Cra/FruK:DNA complex formation is greatly diminished in the presence of F-1-P (see below) and thus that complex is not likely to assemble in the current enzymatic assay. Riggs et al., 1968 , Wong & Lohman, 1993 , and biolayer interferometry (Concepcion et al., 2009) . Experiments were carried out using operator DNA sequences from three different operons: (i) The fruB-prox and fruB-distal operators are bound by Cra to repress the fruBAK genes (Ramseier et al., 1993) ; we report herein that both are high affinity operators.
(ii) The moderate affinity DNA operator aceB is bound by Cra to activate the transcription of malate synthase (Cortay et al., 1994) . And (iii) the DNA operator pfkA is bound by Cra to repress expression of fructose-6-phosphate kinase; this DNA operator lacks the canonical GC basepair between the inverted repeats (Negre et al., 1996) ; the K d estimated for pfkA is 3.5 nM (Negre et al., 1996) .
All experiments were carried out at very low Cra concentrations (50 nM or less); as such, the concentration of co-purifying FruK should be very low. Since adding separately-purified
FruK to Cra elicited a large response in biolayer interferometry assays (see below), this assumption appears to be valid.
Filter binding assays under stoichiometric binding conditions (Swint-Kruse & Matthews, 2004) showed that purified Cra comprised 70-90% active repressor protein. For Cra binding to the DNA operator aceB, the filter binding technique was used to determine a DNA binding affinity of 1.7 ± 0.5 x 10 -9 M ( Figure 6A ), which is in very good agreement with the published value of 3 nM (Ramseier et al., 1993) . Filter binding was also used to determine a K d value of 1.8 ± 0.1x10 -11 M for Cra binding to both the fruB distal and proximal DNA operators ( Figure 6B ).
When purified FruK was added to determine the effect of complex formation on Cra:DNA binding, the filter was saturated with protein, precluding the use of this assay. Thus, we turned to biolayer interferometry (Concepcion et al., 2009) . In this assay, one component of the binding reaction is immobilized to a derivatized fiber-optic tip, which is then dipped into a solution of the second component. Binding is monitored as a function of time via changes in interference patterns of reflected light. As a general rule, the signal increases as the thickness of the immobilized and bound material increases.
For this project, we immobilized biotinylated operator DNA to streptavidin tips, which were then incubated with repressor protein in the presence and absence of FruK and various small molecules. We first benchmarked the assay using the well-characterized binding of the lactose repressor protein (LacI; e.g. (Swint-Kruse et al., 2003 , Zhan et al., 2006 , Falcon & Matthews, 2001 ) and a LacI:PurR chimera (Zhan et al., 2008) to lac operators ( Supplementary   Figures 3-6 ). These experiments showed that the plateau of the association phase correlated with the percent of repressor bound ( Figure 7 and Supplementary Figure 5) . Thus, we used this parameter to monitor effects of F-1-P and F-1,6-BP on DNA binding to Cra and to the Cra/FruK complex. Since the association and dissociation rates of the control proteins and Cra showed complicated kinetic phases ( Figure 7B and Supplementary Figures 4-5) , we did not quantify rate parameters.
Representative data from biolayer interferometry are shown in DNA. In parallel with the behavior documented for LacI (Lin & Riggs, 1975a , Lin & Riggs, 1975b , Elf et al., 2007 , Taraban et al., 2008 (Supplementary Figure 5) , induced Cra retained weak affinity for DNA; the signal did not fall to zero.
Next, we pre-incubated Cra with excess FruK and repeated DNA binding experiments.
Relative to Cra-only, the amplitude for Cra/FruK binding greatly increased (Figure 8 Pre-incubating Cra/FruK with 1 mM F-1-P or 10 mM F-1,6-BP showed a striking result ( Figure 8B ): As with Cra only, F-1-P served as an inducer (decreased amplitude). In contrast, the presence of F-1,6-BP increased the amplitude of Cra/FruK binding. This result indicates that F-1,6-BP must either enhance formation of the Cra/FruK complex, enhance DNA binding by the complex, or both. The same trend was observed for all three DNA operator sequences, with two different lengths of flanking DNA. Further, the LLhF chimera showed the same patterns when binding to lac DNA operator in the absence and presence of FruK, F-1-P, and F-1,6-BP (Supplementary Figure 9) . We note that these experiments do not discriminate whether the effect arises from F-1,6-BP binding to Cra or from binding to FruK. 11 ). For the Cra:DNA complex, no change was observed from the addition of nucleotide ( Figure 9 ). For the Cra/FruK:DNA complex, addition of 3 mM ATP or ADP caused a slight decrease in the interferometry signal ( Figures 9 and 11) ; addition of 0.3 mM ADP had essentially no impact.
Next, we carried out the forward reaction by alternating additions of F-1-P and ATP to the DNA-immobilized Cra/FruK complex ( Figure 10 ). The resulting signal changes were consistent with the forward reaction, in which F-1-P was converted to F-1,6-BP, thereby enhancing the signal for the Cra/FruK:DNA complex.
To detect the reverse enzymatic reaction, we added F-1,6-BP and then ADP to DNAbound Cra/FruK. The second addition caused a large decrease in the biolayer interferometry signal ( Figure 11) , with a final amplitude very similar to that of [Cra + F-1-P]. This result was consistent with enzymatic conversion of F-1,6-BP to F-1-P, followed by F-1-P binding to and induction of Cra to diminish DNA binding. The effect occurred for even the tightest fruB operator (Supplementary Figure 7) at the decreased concentration of 57 nM FruK and the physiological concentration of 0.3 mM ADP ( Figure 11B ). As a control, we performed similar experiments with 1 mM cyclic AMP with F-1,6-BP; no effect was observed (data not shown).
Next, we directly monitored the effects of varied substrate concentration and order of addition on the protein-DNA complex. To that end, we pre-equilibrated Cra/FruK with immobilized DNA then subsequently added small molecules. Experiments used the fruB operator DNA, 200 nM FruK, and the physiological concentration of ADP (0.3 mM). As was true for 10 mM F-1,6-BP, when 1 mM F-1,6-BP was the first substrate added, the signal increased and the addition of the 0.3 mM ADP initiated the decreasing signal. When 0.3 mM ADP was the first substrate added to the Cra/FruK:DNA complex, the signal did not change appreciably until F-1,6-BP was added. In the presence of 0.3 mM ADP, even 0.013 mM F-1,6-BP was sufficient to initiate the decreasing signal.
We were surprised that no concentration dependence was readily observed over the range of 0.013 mM to 20 mM F-1,6-BP. (The different decay rates seen in panels A and B of Figure 11 are best explained by the different FruK concentrations.) At least two scenarios can explain this behavior: (i) The K m of FruK for F-1,6-BP is below 0.013 mM; note that 0.013 mM is still above the micromolar concentration of F-1-P needed to induce Cra. Or (ii) FruK catalysis of the reverse reaction is much faster than dissociation of the Cra/FruK:fruB complex, which means that the latter is a rate limiting step and cannot be used to quantify the enzymatic assay.
In addition, this assay does not distinguish whether the free or Cra/DNA-bound FruK (or both) is the catalytically active species.
Discussion
E. coli Cra is routinely referred to as a "master regulator" for switching between glycolytic and gluconeogenic metabolism. However, as noted in the introduction, the mechanism of such a metabolic switch has been difficult to fully rationalize using the previously known parameters of (i) strong inducer F-1-P only present when fructose is an available nutrient, and ( To formulate a biological model for the Cra/FruK complex, we have integrated these observations with two here-to-fore unexplained observations by Molchanova et al. (Molchanova et al., 1992) . First, these authors showed that fruK mutant strains of E. coli are unable to grow on lactate a , which they ascribed to a decrease in PEP-synthase (Molchanova et al., 1992) .
Second, they showed that a strain with double fruK, cra knock-outs caused even further decreases in PEP synthase. Notably, lactate is gluconeogenic (Hua et al., 2007) , and many genes in the gluconeogenesis pathway (including PEP synthase) are activated by Cra (Chin et al., 1989) . We propose that Molchanova's results are explained by FruK and/or FruK/F-1-6-BP enhancement of Cra activation. (F-1,6-BP levels are not yet known for lactate carbon source.) This is consistent with our results showing that Cra/FruK and Cra/FruK/F-1,6-BP may better bind DNA than does Cra alone.
Loss of enhanced Cra-FruK activation can also explain the increased glycerol lag time we observed for the Δ fruK strain: Glycerol can either feed into the TCA cycle or be gluconeogenic (Torres et al., 1997) and both pathways are activated by Cra (Saier & Ramseier, 1996 , Ramseier et al., 1995 . When the carbon source switched to glycerol, the wild-type strain would have full Cra/FruK/F-1,6-BP activation of both pathways. (Note in Table 1 Nevertheless, the reverse reaction occurs at concentrations within or well below the physiological range for E. coli (Table 1 ) (Bennett et al., 2009 ). Since our experiments were carried out with excess FruK, they do not resolve whether the Cra-free or bound form of FruK catalyzes the reverse reaction. One possibility is that reverse reactions of the Cra-free FruK play a role somewhere else in the cell. Another possibility is that the reverse FruK reaction acts as a missing component of the proposed (Kochanowski et al., 2013 , Usuda et al., 2010 In our hands, Cra eluted as a dimer from the phosphocellulose purification column, as benchmarked against the tetrameric, dimeric (Swint-Kruse et al., 2005) , and monomeric (Chen & Matthews, 1992) forms of homolog LacI. In contrast, Cozzone and colleagues previously reported tetramerization of His-tagged Cra (Cortay et al., 1994) . However, in the earlier experiment, the presence of co-purifying FruK would not have been apparent. (We have only been able to resolve the two proteins on one type of gel; see Experimental Procedures). These different outcomes may very well indicate that Cra quaternary structure is modulated by interaction with FruK.
A second set of missing parameters pertain to the effects of Cra/FruK on varied DNA sequences. The Cra regulon comprises 24 operons regulated by individual operator sequences (Ravcheev et al., 2014b) , and Cra/FruK complex formation could provide a mechanism for their differential regulation. Notably, the current work did not show a difference in complex formation when binding single DNA operators from three functionally-distinct operons (fruBAK, aceB, and pfkA). However, the fruBAK operon has two strong operator binding sites. If the FruK interaction were to alter Cra quaternary structure, tetrameric Cra could loop two binding sites of an operon and enhance repression of the relevant genes, in parallel to tetrameric LacI (Swint-chimera shows repression consistent with in vivo looping of the lac operon (Meinhardt et al., 2012) .
Finally, we note the intriguing parallel between the Cra/FruK/F-1,6-BP response and the LacI homolog CcpA. CcpA is a central metabolic regulator of Gram positive bacteria that is regulated by both protein-protein interactions (with HPr and CPr) and by F-1,6-BP and glucose-6-phosphate binding to the regulatory domain (Richardson et al., 2015 , Seidel et al., 2005 , Schumacher et al., 2007 . The parallels between Cra and CcpA regulation point to the universal, central role played by the F-1,6-BP metabolite. A number of other examples demonstrate the importance of central metabolism to pathogenicity. For example, sugar use must be balanced between energy generation and biosynthesis of cellular components, such as cell wall/biofilm construction (Forsberg et al., 2012 , Kawada-Matsuo et al., 2012 , Zhang et al., 2012 , Willenborg et al., 2011 . In a second example, enteric pathogens must sense variations in nutrient availability as they move through the gastrointestinal tract and identify the proper region for infection (Gore & Payne, 2010 , Njoroge et al., 2012 . The Cra/FruK interaction in γ -proteobacteria such as E.coli may provide a unique way to target this biology without disturbing metabolism of the mammalian host or beneficial microbes. With the impending doom of antibiotic resistance, this may allow us to re-gain the evolutionary upper hand.
Experimental Procedures

Plasmid construction
Creation of the pHG165a plasmid encoding the LacI:Cra chimera LLhF was reported in 2012 (Meinhardt et al., 2012) . The low copy pHG165 plasmid (Stewart et al., 1986) The growth assay protocol was modified from that of Hall et al. (Hall et al., 2014) . Briefly, both the wild-type and Δ fruK strains were grown in 10 mL rich media (Luria broth) until late-log phase (OD600~1.5 in a cuvette with 1 cm path length). Cultures were then centrifuged at 1800xg for 15 mins, decanted, and resuspended in 1mL "M9" media (182 mM sodium phosphate, 110 mM potassium phosphate monobasic, 93 mM ammonium chloride, 42 mM sodium chloride, 1 mM magnesium sulfate, 0.00005% thiamine, pH 7.4) containing 9 mM MgCl 2 and 0.2% w/v of glucose, glycerol, or fructose as the carbon source, to a starting OD 600 of ~0.1.
The additional MgCl 2 was to facilitate FruK activity and complex formation, which both require Mg 2+ . Subsequently, 100µL of resuspended bacteria were aliquoted into quadruplicate wells of a 96-well plate (Becton Dickinson, NJ).
Bacterial growth was then monitored using either a BioTek Synergy2 microplate reader (Winooski, VT) or a Tecan M200 pro (Switzerland) with data collection via either Gen5 or Magellan data analysis software. During these experiments, the plate was kept at 37 °C with shaking (198.4 rpm); the OD 600 was measured every 15 mins for 24 hours. Media-only wells served as blanks and were subtracted from bacteria-containing wells. Doubling times were calculated for the logarithmic growth phase using the inverse slope of log 2 (OD 600 ) values. Data shown are the mean and standard deviation of quadruplicates samples from each of four independent experiments; unpaired t-tests using were used to assess differences in growth rates. The growth delay time as the WT and Δ fruK strains transitioned from rich to minimal media (t delay ) was calculated as the mean time required for bacteria to reach mid-log phase (OD 600 0.15). Data shown are the mean and standard deviation of quadruplicates samples from each of four independent experiments; paired t-tests were applied to determine statistical differences in growth delay. All calculations were performed with GraphPad Prism v7.0.
Biotinylated DNA
For pulldown assays and biolayer interferometry, full-length biotinylated DNA was either purchased from Integrated DNA Technologies (Skokie, Illinois) or amplified in a thermocylcer using a short oligo of DNA containing a biotin tag and primers encoding the desired DNA operator sequences. For the latter, the single stranded DNA oligos were mixed in a 1:1 ratio in Taq polymerase buffer that contained 2.5 mM dNTPs and 2.5 units Taq Polymerase (New England Biolabs). The mixture was heated to 95° C for 1 minute, then the temperature was reduced 5° C per minute until the temperature reached 35° C. Product formation was verified via electrophoresis on a 2.5% agarose gel.
Sources for F-1-P, F-1,6-BP, ATP, and ADP and ion exchange of F-1-P
Early enzyme assays and DNA binding experiments used the highly soluble sodium salt of F-1-P obtained from Sigma-Aldrich (St. Louis, MO). When that compound was discontinued,
we purchased the less-soluble barium salt of F-1-P from the same company. To obtain the F-1-P concentrations necessary for enzymatic assays, we performed ion exchange chromatography of the barium salt using a Dowex 50WX4 (Sigma) column pre-charged with 2 N HCl and then equilibrated in ddH 2 O. The barium F-1-P was passed through this column several times and the pH of the final eluant was adjusted to 7 with NaOH. Eluted F-1-P was lyophilized and used to make saturated stock solutions in ddH 2 O. Concentrations of the stock solutions were determined by stoichiometric implementations of the enzyme assay (see below).
The trisodium salt of D-fructose-1,6-bisphosphate (F-1,6-BP) was purchased from Sigma-Aldrich (St. Louis, MO). ATP and ADP were purchased from Sigma-Aldrich (St. Louis, MO). For experiments, these nucleotides were dissolved in water and the pH was adjusted to 7.0.
DNA pull-down assays
For pull-down assays, plasmids encoding either the LLhF chimera or wild-type Cra were transformed into the E.coli strain 3.300. Cultures were grown at 37°C to saturation in 3 mL of MOPS minimal media (Teknova, Hollister, CA: 40 mM morpholinopropanesulfonic acid, 10 mM NH 4 Cl, 4 mM tricine, 50 mM NaCl, and other trace metals listed for product number M2101) supplemented with 0.8% glycerol, 1.32 mM dibasic potassium phosphate, 10 mM NaHCO 3 , 0.2% casamino acids, 0.0025% thiamine and 100 μ g/ml ampicillin (Neidhardt et al., 1974 , Bhende & Egan, 1999 . Cells were pelleted by centrifugation, resuspended in 100 In pull-down assays with either LLhF or Cra, a second, slightly smaller protein band was visible. To date, the only gel that resolves the repressor from the second band is the Phast-gel 10-15% gradient, (GE Healthcare, Piscataway, NJ; catalogue #: 17-0540-01).
Mass Spectrometry
For protein identification, the two bands from the pull-down gel were excised and sent to the Mass Spectrometry Core Laboratory at KUMC for analysis; this confirmed the identity of LLhF in the top band and identified the second band as FruK. To that end, the cut-out bands were subjected to trypsin digestion and submitted for mass spectrometry analyses. Results were analyzed using the Sequest algorithm to search an E. coli protein database derived from the NCBInr repository on February 2, 2011. Trypsin specificity was requested, with a maximum of two missed cleavages. Oxidation of methionine, deamidation of asparagine and glutamine, and carboxymethylation of cysteine (defined as a fixed modification) were defined as variable modifications. Statistical criteria for peptide identification included: a minimum XC of 1.8, 2.5 or 3.5 for a peptide ion with a charge of 1, 2, or 3, respectively, a minimum Delta Cn of 0.01, and a probability of 0.001. For protein identification, a minimum of two unique peptides was required.
Results are shown in Supplementary Table 1 .
Cra and LLhF purification
Cra: The plasmid encoding wild-type Cra was constitutively expressed in E.coli B ompT, Hercules, CA) and was generally 0.1-0.2 mg/ml (4.2 μ M, assuming 100% Cra).
LLhF: The LacI:Cra chimera LLhF was purified similarly to wild-type Cra. However, when expressed from the low-copy pHG165a plasmid, the chimera purified as a complex with 
FruK purification
For protein expression, the FruK-pET-3a plasmid (Veiga-da-Cunha et al., 2000) We also obtained better expression/purification by inducing FruK expression at the end of the previously published induction window of 0.4-0.6 OD 600 : We grew 1 L M9 media for 3-5 hours at 37°C until OD 600 reached 0.6, then induced with 1 mM isopropyl-1-thio-β-Dgalactopyranoside (IPTG). Induced cultures were incubated at 22°C with shaking at 220 rpm for an additional 44-45 hours. Cells were pelleted at 7,000 rpm for 15 min and resuspended in 50 mL of FruK breaking buffer (20 mM potassium phosphate, 5mM EDTA, 1 mg/mL lysozyme, 1
Pierce Protease Inhibitor Tablet (Thermo Scientific, Rockford, IL], 1mM DTT, pH 7.4). The crude cell lysate was cleared by centrifugation, and protein purification proceeded as described (Veiga-da-Cunha et al., 2000) using a Sephadex G25 column for the desalting step and DEAEsepharose for the anion exchange.
After the final column, the FruK fractions were brought to 20% glycerol prior to freezing at -80°C. Protein concentrations were generally around 0.065 mg/ml, as determined by Bio-Rad assays. We attempted to remove the glycerol by dialysis prior to enzyme assays, but found that without this osmolyte, the FruK enzymatic activity decayed over the course of repeated assays (30 min -1 hour). A broad survey of other freezing methods, temperatures, and using glucose as a cryoprotectant showed that glycerol was superior for maintaining enzymatic activity. Thus, the enzyme and DNA binding assays used FruK with 20% glycerol.
FruK enzyme assay
The published assay for FruK activity (Veiga-da-Cunha et al., 2000) was successfully repeated, but we found that the commercial aldolase used as a coupling enzyme had inconsistent and sometimes quite high activity towards F-1-P. Therefore, we devised a new assay by coupling the FruK reaction to that of pyruvate kinase from rabbit muscle (Roche, A stoichiometric implementation of the PYK-coupled assay was used to determine the concentration of the ion-exchanged F-1-P. This assay used a high concentration of FruK so that catalysis of the F-1-P substrate was quickly completed. The change in amplitude at 340 nm was used to determine the total amount of NADH consumed during the reaction; this value corresponds 1:1 with the F-1-P concentration.
Cra-DNA binding assays
Cra-DNA binding assays were carried out in the absence and presence of added, purified FruK. For the FruK-free experiments, we were concerned about the contaminating FruK that co-purified with both Cra and LLhF. However, the repressor proteins were diluted ≥ 10-fold, to a final concentration of 100 nM or less for DNA binding assays. This appeared to dilute contaminating FruK to levels below those required for significant complex formation, as evidenced by the effects observed when high concentrations of FruK were added to the Cra-DNA binding reactions. We did find that some Cra preparations with low concentrations after purification (from the edges of the elution peak) had a higher percent FruK contamination:
When these protein samples were concentrated for biolayer interferometry assays, F-1,6-BP additions on "Cra" had the outcome expected for the Cra/FruK complex.
One type of DNA-binding assay used the strategy of nitrocellulose filter binding (Amersham Protran 0.45 μ m, GE Healthcare Life Sciences) with 32 P-labeled operator DNA (Table 2) , as described previously (Swint-Kruse et al., 2003 , Zhan et al., 2006 , Falcon & Matthews, 2001 , Riggs et al., 1968 , Wong & Lohman, 1993 . Experiments used two different buffers: (i) "FBB" of the LacI DNA binding assays (10 mM Tris, 150mM KCl, 10 mM EDTA, 0.3 mM DTT, pH 7.4, 0.1 mg/ml bovine serum albumin [BSA]), and (ii) the enzyme assay buffer of Viega de Cunha (listed above). The different buffers had little or no impact on K d values, which was especially surprising given the variation in salt concentrations. Control experiments with varied salt and pH indicated that the differences in these two parameters directly offset each other, so that the two buffers appeared equivalent. For stoichiometric assays, the DNA concentration was fixed at least 10-fold greater than the value of K d ; for equilibrium assays, the DNA concentration was fixed at least 10-fold less than the value of K d (Swint-Kruse & Matthews, 2004) . Experiments were repeated multiple times, using at least two different preparations of protein and both buffers. Table 2 ). To that end, tips were first hydrated for at least 10 minutes in the DNA immobilization buffer, loaded with biotinylated DNA (120 sec), washed in immobilization buffer (30 sec), and then dipped into pre-equilibrated solutions of protein(s) and any small molecules.
Immobilization buffer (50 mM Hepes, 0.1 M KCl, 0.1 mM EDTA, 10 mM MgCl 2 , pH 7.0, 0.3 mM DTT) was similar to the PYK buffer used in the FruK enzyme assay.
Most experiments used Streptavidin-derivatized tips (Forté Bio, Pall Life Sciences, Menlo Park, CA), which had low nonspecific binding to either Cra or FruK in the absence of DNA; however tip-to-tip amplitudes were less reproducible. For later experiments, a second "High-Precision Streptavidin" tip became available from Forté-Bio that had better tip-to-tip reproducibility but greater nonspecific binding of Cra and FruK in the absence of DNA. The latter was blocked by adding 0.1 mg/mL BSA to the initial hydration buffer.
For DNA loading, immobilization buffer contained 20-240 nM biotinylated DNA; most experiments used 80 nM. Protein solutions were kept on ice until added to final reaction tube, which was then allowed to warm to room temperature (~15 min). (Biolayer interferometry signals are highly temperature dependent.) All biolayer interferometry steps were carried out with shaking at 2,200 rpm. Resulting signal changes were monitored as a function of time. In other experiments, the Cra or Cra/FruK proteins were first equilibrated with the immobilized DNA and either buffer or solutions of the relevant small molecules were added at later times.
We first benchmarked the biolayer interferometry assays using the well-characterized DNA-binding events of LacI (e.g. (Swint-Kruse et al., 2003 , Zhan et al., 2006 , Falcon & Matthews, 2001 ) and the LacI:PurR chimera "LLhP" (Zhan et al., 2008) ( Supplementary   Figures 3-6 ; additional references cited in the Supplement are listed here (Oehler et al., 1990 , Pfahl et al., 1979 , Gilbert & Maxam, 1973 ); these proteins are homologs of Cra and LLhF (Swint-Kruse & Matthews, 2009 , Meinhardt et al., 2012 . In general, the repressors showed complicated, multi-phasic kinetics which could not be used to determine quantitative association and dissociation rate constants. However, when the protein concentrations were fixed at low values, the amplitudes at equilibrium correlated with the percent of bound repressor predicted The performance of biolayer interferometry experiments could also be improved by pretreatment of the Cra and FruK proteins. For Cra, the amplitude of the biolayer interferometry signal was enhanced by exchanging the KP purification buffer for the PYK enzyme assay buffer using VivaSpin concentrators with a MWCO of 10,000 Da. To that end, the Cra protein sample was diluted 1:5 with buffer and concentrated ~15 fold; this was repeated two more times prior to experiment. Since the final Cra concentration in the binding experiment was unchanged, we hypothesize that one of the KP buffer components diminished DNA binding activity; similar buffer effects were seen in the filter binding assay.
For FruK, aliquots that eluted at the leading edge of the peak from the DEAE column had some contaminant that was not present in the lagging edge. In biolayer interferometry experiments, this contaminant appeared to stimulate catalysis of F-1,6-BP to create the strong inducer F-1-P (Supplementary Figure 10) . The contaminant was separated from the FruK using a VivaSpin concentrator with a MWCO of 10,000 Da to carry out buffer exchange into fresh
FruK purification buffer, using the same dilution parameters as Cra buffer exchange. The resulting FruK had the same behavior towards FBP as protein purified from lagging end of the peak (Supplementary Figure 10) . Adding the filtrate back to the reaction reproduced the apparent stimulation of catalysis for F-1,6-BP. These observations lead us to hypothesize that the affected FruK co-purifies with bound ADP (the other required substrate for the reverse catalytic reaction), which would indicate very high affinity of FruK for ADP.
For the Cra and Cra/FruK measurements, a day's experiments typically used one operator DNA binding to: Cra, Cra+F-1-P, Cra+F-1,6-BP, Cra+FruK, Cra+FruK+F-1-P, and
Cra+FruK+F-1,6-BP. Each set of experiments was repeated on separate days with different Cra and FruK preparations. From these, we determined that the day-to-day reproducibility of the equilibrium amplitude was ~20% and that trends observed within each day's work were reproducible on separate days. Repetitions used either of two lengths of DNA, which had the operator sequence embedded in either a 45mer or 69mer sequence. No DNA length dependence was observed.
For most experiments, Cra concentration was 50 nM. When present, FruK concentration was 200 nM and generally constituted ~ 1/15 th of the final reaction volume.
Because the FruK storage buffer differed significantly from the Cra storage buffer and contained 20% glycerol, we performed control experiments comprising Cra (i) pre-incubated with equivalent volumes of FruK storage buffer and (ii) with added glycerol; no effects were observed on DNA binding.
When fructose metabolites were included in the Cra and Cra/FruK DNA binding reactions, their final concentrations were 1 mM F-1-P and 10 mM F-1,6-BP unless otherwise indicated. When the ATP and ADDP nucleotides were included in the reactions, final concentrations were 3 mM unless otherwise indicated.
In several experiments with the Cra/FruK complex, we noted that the signal at "equilibrium" reached a maximal value and then diminished. Repetitions with freshly thawed aliquots showed this was due, at least in part, to FruK inactivation and/or destabilization over time. Interestingly, Cra/FruK samples with F-1,6-BP showed much less propensity for FruK inactivation. DNA binding affinity, selectivity, and allostery can be altered by amino acid substitution of nonconserved residues in a LacI/GalR homologue. Biochemistry 47: 8058-8069. (Bennett et al., 2009) . The concentration of F-1-P was not determined in this study. b ATP differences between glucose and glycerol growth conditions were not statistically significant. c ADP differences between the three growth conditions were not statistically significant. (Negre et al., 1996) . (Mazumdar et al., 2010 , Fuchs et al., 2012 . between data points. The fruB sequence used was that of the proximal operator ( Table 2 ).
Note that the amplitude at equilibrium correlated with the expected percent bound for the three operators. In control experiments, similar results were observed for the lactose repressor protein binding to its operator DNA sequences (Supplementary Figures 5-6 ). Biotinylated pfkA DNA was immobilized to streptavidin tips from an 80 nM solution. Cra (50 nM)
was pre-equilibrated with 200 nM FruK and bound to the DNA. Addition of the inducer F-1-P (1 mM) diminished the signal, as did the initial addition of 3 mM ATP. However, as FruK catalysis generated F-1,6-BP from these substrates, the signal change reversed and began to increase.
Similar effects were observed for a second cycle of F-1-P and ATP additions, with catalysis apparently occurring after each step and reversing the signal change. We attribute the diminished response of these later steps to the build-up of F-1-P (either uncatalyzed or via the reverse reaction), which binds Cra (and perhaps Cra-FruK) with μ M affinity and diminishes DNA binding. expected (dotted line). When 3 mM ADP was added after F-1,6-BP, the signal dramatically decreased (dotted line), which we attribute to the catalytic creation of the strong inducer F-1-P.
In the control experiment, addition of 3 mM ADP slightly diminished the signal (solid line).
(B) Addition of 10 mM F-1,6-BP enhanced formation of the Cra/FruK:DNA complex even at the
